Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell Carcinoma

20250 citationsJournal Articlegold Open Access

Authors

Omid Yazdanpanah · University of California, Irvine

A. Mahadevan · University of California, Irvine

David J. Benjamin · Hoag Memorial Hospital Presbyterian

Elham Vosoughi · University of California, Irvine

Ali Raad · Comprehensive Clinical Trials

Madina Popal · Comprehensive Clinical Trials

Piyanuch Kongtim

Abstract

This study unveils differences between patients and oncologists' treatment preferences for mRCC and underscores the importance of individualized discussion with each patient to evaluate his or her therapeutic objectives.

Topics & Keywords

Renal cell carcinoma treatment Cancer survivorship and care Economic and Financial Impacts of Cancer

Publication Details

Published in: Cancer Treatment and Research Communications

Volume 46, pp. 101067-101067

DOI: 10.1016/j.ctarc.2025.101067

Field-Weighted Citation Impact: 0.00

Command Palette

Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell Carcinoma

Authors

Abstract

Topics & Keywords

Publication Details